Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03836261 |
|---|---|
| Brief Title: | Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (AMPLIFY) |
| First Submitted : | February 6, 2019 |
| First Submitted that Met QC Criteria : | February 8, 2019 |
| First Posted : | February 11, 2019 |
| Last Update Submitted that Met QC Criteria : | April 15, 2024 |
| Last Update Posted : | April 16, 2024 |